Maria Tsoli

High Street
Randwick, NSW 2052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma.

A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma.

Journal: Neuro-oncology advances

Published: April 30, 2026

Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development.

Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development.

Journal: Cancer metastasis reviews

Published: February 10, 2026

Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma.

Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma.

Journal: Science translational medicine

Published: January 14, 2026

Precision-guided therapy in H3K27-altered diffuse midline glioma.

Precision-guided therapy in H3K27-altered diffuse midline glioma.

Journal: Nature communications

Published: May 30, 2025

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device.

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device.

Journal: Journal of visualized experiments : JoVE

Published: May 19, 2025

Germline analysis of an international cohort of pediatric diffuse midline glioma patients.

Germline analysis of an international cohort of pediatric diffuse midline glioma patients.

Journal: Neuro-oncology

Published: March 12, 2025

High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.

High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.

Journal: Neuro-oncology

Published: February 12, 2025

RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition.

RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition.

Journal: Cell death & disease

Published: January 02, 2025

Chemotherapy reprograms miRNA expression profiles in apoptotic extracellular vesicles from medulloblastoma cells, regulating pro- and anti-proliferative effects on recipient drug-naïve cells.

Chemotherapy reprograms miRNA expression profiles in apoptotic extracellular vesicles from medulloblastoma cells, regulating pro- and anti-proliferative effects on recipient drug-naïve cells.

Journal: Cell communication and signaling : CCS

Published: December 18, 2024

Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.

Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 27, 2024

Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomas.

Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomas.

Journal: Neuro-oncology advances

Published: March 29, 2024

From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients.

From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients.

Journal: Biomedicines

Published: September 29, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026